| Literature DB >> 32173028 |
Rebecca Pavlos1, Pooja Deshpande2, Abha Chopra3, Shay Leary3, Kaija Strautins3, David Nolan4, Daren Thorborn5, Mark Shaefer6, Andri Rauch7, David Dunn3, Julio Montaner8, Anita Rachlis9, Coral-Ann Almeida10, Linda Choo3, Ian James3, Alec J Redwood11, Yueran Li12, Silvana Gaudieri13, Simon A Mallal14, Elizabeth J Phillips15.
Abstract
Abacavir hypersensitivity syndrome (ABC HSS) is strongly associated with carriage of human leukocyte antigen (HLA)-B*57:01, which has a 100% negative predictive value for the development of ABC HSS. However, 45% of individuals who carry HLA-B*57:01 can tolerate ABC. We investigated immune and non-immune related genes in ABC HSS (n = 95) and ABC tolerant (n = 43) HLA-B*57:01 + patients to determine other factors required for the development of ABC HSS. Assignment of phenotype showed that ABC HSS subjects were significantly less likely than tolerants to carry only ERAP1 hypoactive trimming allotypes (p = 0.02). An altered self-peptide repertoire model by which abacavir activates T cells is in keeping with observation that endoplasmic reticulum aminopeptidase 1 (ERAP1) allotypes that favour efficient peptide trimming are more common in ABC HSS patients compared to patients who tolerate ABC. Independently, non-specific immune activation via soluble cluster of differentiation antigen 14 (sCD14) may also influence susceptibility to ABC HSS.Entities:
Keywords: Abacavir hypersensitivity syndrome; Endoplasmic reticulum aminopeptidase 1; Human leukocyte antigen
Mesh:
Substances:
Year: 2020 PMID: 32173028 PMCID: PMC7266722 DOI: 10.1016/j.humimm.2020.02.011
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850